Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry.
Saved in:
| Title: | Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry. |
|---|---|
| Authors: | Chartier, Karen G., Sanchez, Katherine, Killeen, Therese K., Burrow, Allison, Carmody, Thomas, Greer, Tracy L., Trivedi, Madhukar H. |
| Source: | American Journal on Addictions. Jun2015, Vol. 24 Issue 4, p336-340. 5p. 2 Charts. |
| Subjects: | Clinical trials, Drug abstinence, Symptoms, Gender differences (Sociology), Institutional care, Bivariate analysis, Diseases in African Americans |
| Abstract: | Background and Objectives Gender-specific factors associated with stimulant abstinence severity were examined in a stimulant abusing or dependent residential treatment sample ( N = 302). Method Bivariate statistics tested gender differences in stimulant abstinence symptoms, measured by participant-reported experiences of early withdrawal. Multivariate linear regression examined gender and other predictors of stimulant abstinence symptom severity. Results Women compared to men reported greater stimulant abstinence symptom severity. Anxiety disorders and individual anxiety-related abstinence symptoms accounted for this difference. African American race/ethnicity was predictive of lower stimulant abstinence severity. Discussion and Conclusions Women were more sensitive to anxiety-related stimulant withdrawal symptoms. Scientific Significance Clinics that address anxiety-related abstinence symptoms, which more commonly occur in women, may improve treatment outcome. (Am J Addict 2015;XX:XX -XX) [ABSTRACT FROM AUTHOR] |
| Copyright of American Journal on Addictions is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Background and Objectives Gender-specific factors associated with stimulant abstinence severity were examined in a stimulant abusing or dependent residential treatment sample ( N = 302). Method Bivariate statistics tested gender differences in stimulant abstinence symptoms, measured by participant-reported experiences of early withdrawal. Multivariate linear regression examined gender and other predictors of stimulant abstinence symptom severity. Results Women compared to men reported greater stimulant abstinence symptom severity. Anxiety disorders and individual anxiety-related abstinence symptoms accounted for this difference. African American race/ethnicity was predictive of lower stimulant abstinence severity. Discussion and Conclusions Women were more sensitive to anxiety-related stimulant withdrawal symptoms. Scientific Significance Clinics that address anxiety-related abstinence symptoms, which more commonly occur in women, may improve treatment outcome. (Am J Addict 2015;XX:XX -XX) [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 10550496 |
| DOI: | 10.1111/ajad.12190 |
